5-Trimethylstannyl-pyrimidine → (5S*,9R*)-7-Benzyl-3-(3,5-dichlorophenyl)-1-methyl-9-(4-pyrimidin-5-yl-phenyl)-1,3,7-triazaspiro[4.4]nonane-2,4-dione

HRID 1792880ノート

反応式

HRID 1792880 の反応式
[CH2:1]([N:8]1[CH2:27][C@@H:26]([C:28]2[CH:33]=[CH:32][C:31](Br)=[CH:30][CH:29]=2)[C@:10]2([N:14]([CH3:15])[C:13](=[O:16])[N:12]([C:17]3[CH:22]=[C:21]([Cl:23])[CH:20]=[C:19]([Cl:24])[CH:18]=3)[C:11]2=[O:25])[CH2:9]1)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.C[Sn](C)(C)[C:37]1[CH:38]=[N:39][CH:40]=[N:41][CH:42]=1>C1(C)C=CC=CC=1.C1C=CC([P]([Pd]([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)[P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)=CC=1>[CH2:1]([N:8]1[CH2:27][C@@H:26]([C:28]2[CH:33]=[CH:32][C:31]([C:37]3[CH:38]=[N:39][CH:40]=[N:41][CH:42]=3)=[CH:30][CH:29]=2)[C@:10]2([N:14]([CH3:15])[C:13](=[O:16])[N:12]([C:17]3[CH:22]=[C:21]([Cl:23])[CH:20]=[C:19]([Cl:24])[CH:18]=3)[C:11]2=[O:25])[CH2:9]1)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1

参加物

5

実験手順

A mixture of Example 65 (2 g, 3.58 mmol), 5-trimethylstannyl-pyrimidine (1.3 g, 5.35 mmol, prepared according to patent WO 95/06636) and tetrakis(triphenylphosphine)palladium(0) (620 mg, 0.54 mmol) in toluene (50 ml) was refluxed for 10 h under a nitrogen atmosphere. After cooling to room temperature, the insoluble material was filtered off and washed twice with toluene. The toluene layers were concentrated in vacuo. The resulting orange oil (3.1 g) was chromatographed over silica gel (eluent: EtOAc) to yield the above-titled compound as a white solid after crystallization from MeOH (430 mg), mp=228° C.

後処理

  1. filtrationthe insoluble material was filtered off
  2. washwashed twice with toluene
  3. concentrationThe toluene layers were concentrated in vacuo
  4. customThe resulting orange oil (3.1 g) was chromatographed over silica gel (eluent: EtOAc)

出典と根拠

ORDレコード
ord-824e14e2ee4142ac9fd082ec66eda74c
出典データセット
uspto-grants-2006_07
特許番号
US07078420B2

反応ノート

読み込み中…